Onconetix, Inc. (ONCO): Total Assets
$24.93M
As of 2025-12-31
$16.43M
As of 2026-06-30
-1.8%
3-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $24.93M | -11.5% | 2026-03-13, Balance as of period end |
| 2024-12-31 | $28.18M | -67.8% | 2026-03-13, Balance as of period end |
| 2023-12-31 | $87.52M | +232.6% | 2025-06-02, Balance as of period end |
| 2022-12-31 | $26.31M | +752.9% | 2024-04-11, Balance as of period end |
| 2021-12-31 | $3.08M | n/a | 2023-03-09, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | 2025-12-31 | $24.93M | -11.5% |
| Rallybio Corp (RLYB) | 2025-12-31 | $62.26M | -8.6% |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | $114.11M | +17.8% |
| Lexaria Bioscience Corp. (LEXX) | 2025-08-31 | $4.18M | -52.9% |
| Shattuck Labs, Inc. (STTK) | 2025-12-31 | $91.03M | 0.0% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $5.37M | -6.8% |
| Polomar Health Services, Inc. (PMHS) | 2025-12-31 | $390.0K | -96.1% |
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | $32.47M | +46.9% |
| BioXcel Therapeutics, Inc. (BTAIQ) | 2025-12-31 | $44.92M | +17.2% |
Compare ONCO, RLYB, RFL, LEXX side by side · Screen every company in Pharmaceutical Preparations ↗